|
Volumn 266, Issue 1, 2005, Pages 107-111
|
QSAR study of 125I-labeled 2-(4-aminophenyl)benzothiazole derivatives as imaging agents for β-amyloid in the brain with Alzheimer's disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 (4' ACETYLAMINOPHENYL) 5 CHLOROBENZOTHIAZOLE I 125;
2 (4' ACETYLAMINOPHENYL)BENZOTHIAZOLE I 125;
2 (4' AMINOPHENYL) 5 CHLOROBENZOTHIAZOLE I 125;
2 (4' AMINOPHENYL)BENZOTHIAZOLE I 125;
AMYLOID BETA PROTEIN;
BENZOTHIAZOLE DERIVATIVE;
DIAGNOSTIC AGENT;
UNCLASSIFIED DRUG;
ALZHEIMER DISEASE;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
BRAIN METABOLISM;
BRAIN TISSUE;
CONTROLLED STUDY;
DIAGNOSTIC IMAGING;
DIPOLE;
DRUG DISTRIBUTION;
DRUG UPTAKE;
FEMALE;
IN VIVO STUDY;
MOLECULAR PROBE;
MOLECULE;
MOUSE;
NEUROIMAGING;
NONHUMAN;
PROCESS DEVELOPMENT;
PROTEIN DETERMINATION;
QUANTITATIVE STRUCTURE ACTIVITY RELATION;
TISSUE DISTRIBUTION;
|
EID: 24644451559
PISSN: 02365731
EISSN: None
Source Type: Journal
DOI: 10.1007/s10967-005-0877-4 Document Type: Article |
Times cited : (9)
|
References (16)
|